Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury

Penghai Wang, Hua Chen, Honghua Qin, Sornampillai Sankarapandi, Mark W. Becher, Philip Chun Wong, Jay L. Zweier

Research output: Contribution to journalArticle

Abstract

Superoxide and superoxide-derived oxidants have been hypothesized to be important mediators of postischemic injury. Whereas copper, zinc-superoxide dismutase SOD1, efficiently dismutates superoxide, the has been controversy regarding whether increasing intracellular SOD1 expression would protect against or potentiate cellular injury. To determine whether increased SOD1 protects the heart from ischemia and reperfusion, studies were performed in a newly developed transgenic mouse model in which direct measurement of superoxide, contractile function, bioenergetics, and cell death could performed. Transgenic mice with overexpression of human SOD1 were studied along with matched nontransgenic controls. Immunoblotting and immunohistology demonstrated that total SOD1 expression was increased 10-fold in hearts from transgenic mice compared with nontransgenic controls, with increased expression in both myocytes and endothelial cells. In nontransgenic hearts following 30 min of global ischemia a reperfusion-associated burst of superoxide generation was demonstrated by electron paramagnetic resonance spin trapping. However, in the transgenic hearts with overexpression of SOD1 the burst of superoxide generation was almost totally quenched, and this was accompanied by a 2-fold increase in the recovery of contractile function, a 2.2-fold decrease in infarct size, and a greatly improved recovery of high energy phosphates compared with that in nontransgenic controls. These results demonstrate that superoxide is an important mediator of postischemic injury and that increasing intracellular SOD1 dramatically protects the heart from this injury. Thus, increasing intracellular SOD1 expression may be a highly effective approach to decrease the cellular injury that occurs following reperfusion of ischemic tissues.

Original languageEnglish (US)
Pages (from-to)4556-4560
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number8
DOIs
StatePublished - Apr 14 1998

Fingerprint

Superoxides
Superoxide Dismutase
Zinc
Copper
Wounds and Injuries
Transgenic Mice
Reperfusion
Ischemia
Heart Injuries
Spin Trapping
Recovery of Function
Electron Spin Resonance Spectroscopy
Immunoblotting
Oxidants
Muscle Cells
Energy Metabolism
Cell Death
Endothelial Cells
Phosphates

Keywords

  • Electron paramagnetic resonance
  • Myocardial infarction
  • Nuclear magnetic resonance
  • Superoxide radical
  • Transgenic model

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury. / Wang, Penghai; Chen, Hua; Qin, Honghua; Sankarapandi, Sornampillai; Becher, Mark W.; Wong, Philip Chun; Zweier, Jay L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 8, 14.04.1998, p. 4556-4560.

Research output: Contribution to journalArticle

Wang, Penghai ; Chen, Hua ; Qin, Honghua ; Sankarapandi, Sornampillai ; Becher, Mark W. ; Wong, Philip Chun ; Zweier, Jay L. / Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 8. pp. 4556-4560.
@article{2fbdd31d7ecf4a86ab96f7bf30326f18,
title = "Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury",
abstract = "Superoxide and superoxide-derived oxidants have been hypothesized to be important mediators of postischemic injury. Whereas copper, zinc-superoxide dismutase SOD1, efficiently dismutates superoxide, the has been controversy regarding whether increasing intracellular SOD1 expression would protect against or potentiate cellular injury. To determine whether increased SOD1 protects the heart from ischemia and reperfusion, studies were performed in a newly developed transgenic mouse model in which direct measurement of superoxide, contractile function, bioenergetics, and cell death could performed. Transgenic mice with overexpression of human SOD1 were studied along with matched nontransgenic controls. Immunoblotting and immunohistology demonstrated that total SOD1 expression was increased 10-fold in hearts from transgenic mice compared with nontransgenic controls, with increased expression in both myocytes and endothelial cells. In nontransgenic hearts following 30 min of global ischemia a reperfusion-associated burst of superoxide generation was demonstrated by electron paramagnetic resonance spin trapping. However, in the transgenic hearts with overexpression of SOD1 the burst of superoxide generation was almost totally quenched, and this was accompanied by a 2-fold increase in the recovery of contractile function, a 2.2-fold decrease in infarct size, and a greatly improved recovery of high energy phosphates compared with that in nontransgenic controls. These results demonstrate that superoxide is an important mediator of postischemic injury and that increasing intracellular SOD1 dramatically protects the heart from this injury. Thus, increasing intracellular SOD1 expression may be a highly effective approach to decrease the cellular injury that occurs following reperfusion of ischemic tissues.",
keywords = "Electron paramagnetic resonance, Myocardial infarction, Nuclear magnetic resonance, Superoxide radical, Transgenic model",
author = "Penghai Wang and Hua Chen and Honghua Qin and Sornampillai Sankarapandi and Becher, {Mark W.} and Wong, {Philip Chun} and Zweier, {Jay L.}",
year = "1998",
month = "4",
day = "14",
doi = "10.1073/pnas.95.8.4556",
language = "English (US)",
volume = "95",
pages = "4556--4560",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury

AU - Wang, Penghai

AU - Chen, Hua

AU - Qin, Honghua

AU - Sankarapandi, Sornampillai

AU - Becher, Mark W.

AU - Wong, Philip Chun

AU - Zweier, Jay L.

PY - 1998/4/14

Y1 - 1998/4/14

N2 - Superoxide and superoxide-derived oxidants have been hypothesized to be important mediators of postischemic injury. Whereas copper, zinc-superoxide dismutase SOD1, efficiently dismutates superoxide, the has been controversy regarding whether increasing intracellular SOD1 expression would protect against or potentiate cellular injury. To determine whether increased SOD1 protects the heart from ischemia and reperfusion, studies were performed in a newly developed transgenic mouse model in which direct measurement of superoxide, contractile function, bioenergetics, and cell death could performed. Transgenic mice with overexpression of human SOD1 were studied along with matched nontransgenic controls. Immunoblotting and immunohistology demonstrated that total SOD1 expression was increased 10-fold in hearts from transgenic mice compared with nontransgenic controls, with increased expression in both myocytes and endothelial cells. In nontransgenic hearts following 30 min of global ischemia a reperfusion-associated burst of superoxide generation was demonstrated by electron paramagnetic resonance spin trapping. However, in the transgenic hearts with overexpression of SOD1 the burst of superoxide generation was almost totally quenched, and this was accompanied by a 2-fold increase in the recovery of contractile function, a 2.2-fold decrease in infarct size, and a greatly improved recovery of high energy phosphates compared with that in nontransgenic controls. These results demonstrate that superoxide is an important mediator of postischemic injury and that increasing intracellular SOD1 dramatically protects the heart from this injury. Thus, increasing intracellular SOD1 expression may be a highly effective approach to decrease the cellular injury that occurs following reperfusion of ischemic tissues.

AB - Superoxide and superoxide-derived oxidants have been hypothesized to be important mediators of postischemic injury. Whereas copper, zinc-superoxide dismutase SOD1, efficiently dismutates superoxide, the has been controversy regarding whether increasing intracellular SOD1 expression would protect against or potentiate cellular injury. To determine whether increased SOD1 protects the heart from ischemia and reperfusion, studies were performed in a newly developed transgenic mouse model in which direct measurement of superoxide, contractile function, bioenergetics, and cell death could performed. Transgenic mice with overexpression of human SOD1 were studied along with matched nontransgenic controls. Immunoblotting and immunohistology demonstrated that total SOD1 expression was increased 10-fold in hearts from transgenic mice compared with nontransgenic controls, with increased expression in both myocytes and endothelial cells. In nontransgenic hearts following 30 min of global ischemia a reperfusion-associated burst of superoxide generation was demonstrated by electron paramagnetic resonance spin trapping. However, in the transgenic hearts with overexpression of SOD1 the burst of superoxide generation was almost totally quenched, and this was accompanied by a 2-fold increase in the recovery of contractile function, a 2.2-fold decrease in infarct size, and a greatly improved recovery of high energy phosphates compared with that in nontransgenic controls. These results demonstrate that superoxide is an important mediator of postischemic injury and that increasing intracellular SOD1 dramatically protects the heart from this injury. Thus, increasing intracellular SOD1 expression may be a highly effective approach to decrease the cellular injury that occurs following reperfusion of ischemic tissues.

KW - Electron paramagnetic resonance

KW - Myocardial infarction

KW - Nuclear magnetic resonance

KW - Superoxide radical

KW - Transgenic model

UR - http://www.scopus.com/inward/record.url?scp=0032516036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032516036&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.8.4556

DO - 10.1073/pnas.95.8.4556

M3 - Article

VL - 95

SP - 4556

EP - 4560

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -